Lipid and inflammatory biomarker profiles in early insulin resistance.
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Marcelino Rodríguez, Itahisaca
- dc.contributor.author Oliva García, José Gregorioca
- dc.contributor.author Alemán Sánchez, José Juanca
- dc.contributor.author Almeida González, Deliaca
- dc.contributor.author Domínguez Coello, Santiagoca
- dc.contributor.author Brito Díaz, Buenaventuraca
- dc.contributor.author Gannar, Fadouaca
- dc.contributor.author Rodríguez Pérez, María del Cristoca
- dc.contributor.author Elosua Llanos, Robertoca
- dc.contributor.author Cabrera de León, Antonioca
- dc.date.accessioned 2017-02-27T09:22:37Z
- dc.date.available 2017-02-27T09:22:37Z
- dc.date.issued 2016
- dc.description.abstract AIMS: To analyze the serum lipid and inflammatory biomarker profile in the early insulin resistance (e-IR). METHODS: Cross-sectional study of 5943 adults without diabetes, stratified into no IR group (C-peptide <third tertile and glucose <100 mg/dL), e-IR group (C-peptide ≥third tertile and glucose <100 mg/dL) and advanced IR group (glucose ≥100 mg/dL). RESULTS: E-IR showed significant differences with no IR in the serum concentration of triglycerides (P < 0.001), HDL cholesterol (P < 0.001), LDL cholesterol (P < 0.001), sCD40L (P < 0.001), C-reactive protein (P < 0.004), leptin (P < 0.001) and adiponectin (P < 0.001). Adjusting for age, gender and abdominal obesity, corroborated the association of e-IR with highest quintile of triglycerides (OR 3.88 [3.07-4.89]), HDL cholesterol (OR 0.35 [0.28-0.44]), sCD40L (OR 0.47 [0.24-0.94]), C-reactive protein (OR 2.31 [1.29-4.12]), adiponectin (OR 0.11 [0.04-0.32]), PAI-1 (OR 3.29 [1.29-8.40]) and resistin (OR 1.25 [1.01-1.54]); the same biomarkers were associated with advanced IR although resistin was a protective factor (OR 0.73 [0.58-0.93]). CONCLUSIONS: Euglycemic patients with e-IR present an unfavorable serum lipid and inflammatory biomarker profile. Measuring C-peptide in euglycemic patients with elevated triglycerides identifies e-IR.ca
- dc.description.sponsorship Funding Canary Islands Health Service. Spanish Government (Instituto de Salud Carlos III, Projects 0901314, PI12/01855, and RD12/0042/0031 and 0013. FEDER).
- dc.format.mimetype application/pdfca
- dc.identifier.citation Marcelino Rodríguez I, Oliva García J, Alemán Sánchez JJ, Almeida González D, Domínguez Coello S, Brito Díaz B. et al. Lipid and inflammatory biomarker profiles in early insulin resistance. Acta Diabetol. 2016 Dec;53(6):905-913ca
- dc.identifier.doi http://dx.doi.org/10.1007/s00592-016-0885-6
- dc.identifier.issn 0940-5429
- dc.identifier.uri http://hdl.handle.net/10230/28141
- dc.language.iso engca
- dc.publisher Springerca
- dc.relation.ispartof Acta Diabetologica. 2016 Dec;53(6):905-13
- dc.rights © Springer The final publication is available at Springer via http://dx.doi.org/10.1007/s00592-016-0885-6.ca
- dc.rights.accessRights info:eu-repo/semantics/embargoedAccessca
- dc.subject.other Insulinaca
- dc.subject.other Marcadors bioquímicsca
- dc.subject.other Lípidsca
- dc.title Lipid and inflammatory biomarker profiles in early insulin resistance.ca
- dc.type info:eu-repo/semantics/articleca
- dc.type.version info:eu-repo/semantics/acceptedVersionca